← ICICI Prudential Mutual Fund

ICICI Prudential Nifty Pharma Index Fund - Direct Plan - Growth

Index/ETF Data as of Apr 2026 Comparing Mar 2026 → Apr 2026
Share: WhatsApp X
Stocks Held
20
Apr 2026
Equity Holdings
₹113.38 Cr
Equity only, excl. debt & cash
Top 5 Weight
57.0%
High concentration
Top 10 Weight
79.7%
High concentration
Changes
22
2 new · 2 exits
Top Sector
Pharmaceuticals & Biotechnology
100.0% of portfolio
📋 What Happened This Month ICICI Prudential Nifty Pharma Index Fund made 2 new additions and exited 2 stocks this month. The biggest new buy was Wockhardt Limited (Pharmaceuticals & Biotechnology) at 1.36% weight. Natco Pharma Limited was the biggest exit (Pharmaceuticals & Biotechnology), which was held at 0.95%. Among existing holdings, Laurus Labs Limited saw the biggest increase — now at 5.04% of the portfolio. Sun Pharmaceutical Industries Limited was trimmed the most, now at 22.53%. Sun Pharmaceutical Industries Limited remains the top holding with Pharmaceuticals & Biotechnology the dominant sector at 100.0%. ↓ Scroll down for full holdings, sector allocation and month-on-month changes in detail.
Sector Shift Industry allocation month-over-month
Feb 2026 Mar 2026
Sector Prev Curr Delta
Pharmaceuticals & Biotechnology 99.4% 99.3% 0.0%
Mar 2026 Apr 2026
Sector Prev Curr Delta
Pharmaceuticals & Biotechnology 99.3% 100.0% +0.6%
🟢
Biggest New Buy
Wockhardt Limited
1.36% weight · Pharmaceuticals & Biotechnology
🔴
Biggest Exit
Natco Pharma Limited
0.95% was held · Pharmaceuticals & Biotechnology
Biggest Add
Laurus Labs Limited
+1.86% · now 5.04%
Biggest Trim
Sun Pharmaceutical Industries Limited
-2.21% · now 22.53%
🤝 Other funds also bought this month
Piramal Pharma Limited 17 funds
Piramal Pharma Limited
ICICI Prudential Conglomerate Fund - Direct Plan - Growth
HDFC Flexi Cap Fund - Growth Option - Direct Plan
ICICI Prudential Nifty Healthcare ETF + more
Wockhardt Limited 17 funds
Wockhardt Limited
HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan
Mirae Asset ELSS Tax Saver Fund - Direct Plan - Growth
ITI Value Fund - Direct Plan - Growth Option + more
👋 Other funds also exited
Granules India Limited 2 funds
Granules India Limited
ICICI Prudential Nifty Healthcare ETF
Edelweiss Balanced Advantage Fund -Direct Plan-Growth Option

What Changed?

Comparing Mar 2026 → Apr 2026

Mar 2026 Apr 2026
🟢 2 New Entries 🔴 2 Exits ↑ 10 Increased ↓ 8 Decreased
#StockSectorWeight (Apr 2026)
1
Wockhardt Limited
₹1.54 Cr
Pharmaceuticals & Biotechnology 1.36%
2
Piramal Pharma Limited
₹1.34 Cr
Pharmaceuticals & Biotechnology 1.18%
#StockSectorLast Weight (Mar 2026)
1
Natco Pharma Limited
₹76.20 L
Pharmaceuticals & Biotechnology 0.95%
2
Granules India Limited
₹75.13 L
Pharmaceuticals & Biotechnology 0.93%
#StockSectorMar 2026Apr 2026Change
1
Laurus Labs Limited
₹5.72 Cr
Pharmaceuticals & Biotechnology 3.18% 5.04% +1.86%
2
Glenmark Pharmaceuticals Limited
₹4.84 Cr
Pharmaceuticals & Biotechnology 3.07% 4.26% +1.19%
3
Biocon Limited
₹3.43 Cr
Pharmaceuticals & Biotechnology 2.04% 3.02% +0.98%
4
Torrent Pharmaceuticals Limited
₹5.84 Cr
Pharmaceuticals & Biotechnology 4.46% 5.15% +0.69%
5
JB Chemicals & Pharmaceuticals Limited
₹2.23 Cr
Pharmaceuticals & Biotechnology 1.54% 1.97% +0.43%
6
Alkem Laboratories Limited
₹4.21 Cr
Pharmaceuticals & Biotechnology 3.43% 3.72% +0.29%
7
Aurobindo Pharma Limited
₹5.18 Cr
Pharmaceuticals & Biotechnology 4.29% 4.57% +0.28%
8
Dr. Reddy's Laboratories Limited
₹10.76 Cr
Pharmaceuticals & Biotechnology 9.23% 9.49% +0.26%
9
Lupin Limited
₹7.46 Cr
Pharmaceuticals & Biotechnology 6.48% 6.58% +0.10%
10
Divi's Laboratories Limited
₹11.03 Cr
Pharmaceuticals & Biotechnology 9.70% 9.72% +0.02%
#StockSectorMar 2026Apr 2026Change
1
Sun Pharmaceutical Industries Limited
₹25.55 Cr
Pharmaceuticals & Biotechnology 24.74% 22.53% -2.21%
2
Cipla Limited
₹9.83 Cr
Pharmaceuticals & Biotechnology 10.73% 8.67% -2.06%
3
Mankind Pharma Limited
₹3.39 Cr
Pharmaceuticals & Biotechnology 3.62% 2.99% -0.63%
4
Abbott India Limited
₹1.76 Cr
Pharmaceuticals & Biotechnology 2.12% 1.55% -0.57%
5
Zydus Lifesciences Limited
₹2.98 Cr
Pharmaceuticals & Biotechnology 2.93% 2.63% -0.30%
6
IPCA Laboratories Limited
₹2.84 Cr
Pharmaceuticals & Biotechnology 2.76% 2.50% -0.26%
7
Ajanta Pharma Limited
₹1.59 Cr
Pharmaceuticals & Biotechnology 1.46% 1.40% -0.06%
8
Gland Pharma Limited
₹1.86 Cr
Pharmaceuticals & Biotechnology 1.68% 1.64% -0.04%

Full Portfolio

20 stocks — Apr 2026

# Stock Sector Cap Weight & Value
1
₹25.55 Cr
Pharmaceuticals & Biotechnology
22.53%
2
₹11.03 Cr
Pharmaceuticals & Biotechnology
9.72%
3
₹10.76 Cr
Pharmaceuticals & Biotechnology
9.49%
4
₹9.83 Cr
Pharmaceuticals & Biotechnology
8.67%
5
₹7.46 Cr
Pharmaceuticals & Biotechnology
6.58%
6
₹5.84 Cr
Pharmaceuticals & Biotechnology
5.15%
7
₹5.72 Cr
Pharmaceuticals & Biotechnology
5.04%
8
₹5.18 Cr
Pharmaceuticals & Biotechnology
4.57%
9
₹4.84 Cr
Pharmaceuticals & Biotechnology
4.26%
10
₹4.21 Cr
Pharmaceuticals & Biotechnology
3.72%
🏆 Top stocks held by Equity funds
See which stocks all active Equity fund managers are buying — ranked by total value invested
🏦 ICICI Prudential Mutual Fund — Portfolio & Holdings
See all funds managed by ICICI Prudential Mutual Fund — conviction stocks, monthly entries & exits

Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.

Found a discrepancy or have feedback? Contact Us — we read every message personally.